Insmed's CEO said months ago that the commercial opportunity for their newly approved biotech lung disease drug is huge.[1] This claim has proven to be true.[1] Insmed is enjoying the success of this drug for lung disease.[1] At the same time, the company is preparing for further steps in connection with this drug.[1]